Additionally, patients with DLB displayed significantly lower levels of plasma p-tau181 (P < 0.001, d = 1.11), NfL (P = 0.037, d = 0.390), and GFAP (P < 0.001, d = 0.685) compared with AD patients. This evidence concerns the gene NEFL and Alzheimer disease.